Accelerating DTx Market Access: Forecasting Future Regulatory and Reimbursement Pathways in Canada

February 13, 2024 1:15pm

Alexis Sciuk head shot

Alexis Sciuk
Global Market Access Policy Strategist
Pfizer

Mia Spiegelman
Vice-President of Regulatory Affairs
Medtech Canada

Moderator:

Ben King
Director, Digital Health & Innovation
Santis Health

  • Defining digital therapeutics
    • Examining examples of how DTx and the potential to benefit different patient populations
  • Developing a DTx access strategy with insights on how regulators, public and private payers are viewing these innovations in Canada
    • Forecasting the future regulatory and reimbursement landscape in Canada
      • Assessing how the US and Europe are approaching reimbursement for digital therapeutics
    • Examining what steps are being taken towards the development of digital formularies
  • Examining the role of digital therapeutics in the RWD ecosystem